- CH₣4.36bn
- CH₣5.45bn
- CH₣4.14bn
Brief: Galenica AG Says FY Consolidated Net Sales Of CHF 3,921.1 Million
Swiss stocks - Factors to watch on January 30
Brief: Galenica Nominates Nadine Balkanyi-Nordmann For The Board Of Directors
Brief: Galenica Confirms 2024 Guidance
Brief: Galenica Increases Sales Growth In The Third Quarter
Galenica falls around 4% after 'underwhelming' results
Brief: Galenica AG: Handover Of Position Of CFO
Swiss stocks - Factors to watch on August 6
Brief: Galenica Says Group Sales Grew 2.6% To Chf 1.9 Bln In HY
Brief: Galenica AG - H1 Group Sales Grew By 2.6% To CHF 1,900.0 Million
Brief: Galenica Notifies Dutch Authority For Financial Markets Of Its 10% Stake In Redcare Pharmacy
Brief: Galenica Confirms FY Outlook
Swiss stocks - Factors to watch on April 17
Brief: Galenica Successfully Places Bond Of Over Chf 100 Million
Swiss stocks - Factors to watch on April 12
Swiss stocks - Factors to watch on April 10
Swiss stocks - Factors to watch on March 12
Brief: Galenica Says Expects Sales Growth Of Between 3%-5% For FY 2024
Brief: Galenica FY Revenue CHF 3,746 Million